Cause

Short Trading: A comprehensive analysis of the controversial strategy and an in-depth analysis of how investors make money from market declines

Short trading is a strategy in which investors make money by taking advantage of predictions that a stock or other asset is expected to fall. The process involves borrowing shares and selling them immediately in the hope of buying them back at a lower price once their price drops, profiting from the difference between the selling and buying prices. Simply put, short trading is a way for investors to make profits through expected negative changes in the market. The Historical Origins of Short Trading The idea of ​​short trading can

A Note On Charity Through Marginal Price Discrimination

Vitalik Buterin via the Vitalik Buterin Blog Updated 2018-07-28. See end note. The following is an interesting idea that I had two years ago that I personally believe has promise and could be easily implemented in the context of a blockchain ecosystem, though if desired it could certainly also be implemented with more traditional technologies (blockchains would help get the scheme network effects by putting the core logic on a more neutral platform). Suppose that you are a restaurant selling sandwiches, and you ordinarily sell sandwiches for $7.50. Why did

Skyward Bound: HDEX brings eFrancisco Motors and LuftCar Together For Groundbreaking Partnership

A New Electric Vertical Take-off and Landing (eVTOL) Project Begins FOR IMMEDIATE RELEASE Camarines Norte, Philippines – January 28, 2024 HDEX is proud to announce that two partners, eFrancisco Motor Corporation and Luftcar have come together to develop a new Electric Vertical Take-off and Landing (eVTOL) project. The focal point of this groundbreaking collaboration is the development of the LUFT PINOY eVTOL powered by Hydrogen. Aron Dutta, Chairman of HDEX, stated, “HDEX was pleased to help facilitate this exciting partnership. What is happening in the Philippines will be the case

eFrancisco Motors and HDEX Sustainable Transit Initiative Accelerates Hydrogen Adoption across the Transportation Sector

Innovative Procurement Powers Hydrogen Adoption in the Philippines MANILLA, PHILIPPINES– eFrancisco Motor Company (eFMC) and HDEX, the world’s first hydrogen exchange, are thrilled to announce a groundbreaking initiative that transcends mere transactions. This endeavor goes beyond innovation; it's a movement towards a more connected and environmentally responsible future for public transportation in the Philippines. Imagine a world where your daily commute not only takes you from point A to B but also contributes to a greater cause – Tied to the heartbeat of the Philippine Peso, the eFMC token brings

MORNINGBASEBALL AND GAME ON MEDIA SOLUTIONS FORGE PARTNERSHIP TO REVOLUTIONIZE THE BASEBALL STREETWEAR INDUSTRY

November 6th, 2023. Los Angeles, CA– MorningBaseball, a start-up baseball apparel company, has partnered with Game On Media Solutions (GOMS), an innovative media, content and sponsorship representation company, with the goal of transforming the baseball streetwear industry. MorningBaseball aims to inspire and motivate baseball players worldwide to achieve their dreams and conquer the challenges they face on their journey to the next level. One of the brand’s goals is to highlight and support athletes in prioritizing their mental and physical well-being and finding a healthy balance between their passion for

Straight out of Tel Aviv. Romrez Drops Show on NEWHD NY & NEWHD LA.

Nov 3, 2023. NEWHD New York, Where Rock Lives, NEWHD Los Angeles, LA’s Rock and Pop, and VNUE Radio are thrilled to announce the launch of NEWHD EDM with the introduction of a dynamic new show hosted by ROMREZ, hailing from Tel Aviv. Starting this weekend, ROMREZ will take the airwaves by storm with an electrifying show that is set to redefine the EDM scene. Tune in every Saturday night from 10:00 PM to 12:00 AM locally on NEWHD NY and NEWHD LA, and don't miss out on the encore

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in

Embracing the True Spirit of Decentralization: Shiba Classic – Your New Haven!

The idea of decentralization has taken front stage in the fast-paced world of cryptocurrencies, promising a more equitable, inclusive, and transparent financial environment. Not all projects, nevertheless, have adhered to these guidelines. Enter Shiba Classic (SHIBC), a game-changer with a team that has a track record of success taking projects from $0 to $100 million. Shiba Classic is an example of what decentralization stands for. The Shiba Classic crew is now all in and prepared to cause a stir in the DeFi community. Unveiling Shiba Classic - A True Beacon

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers